Skip to main content
Cancer Explained

Disponible en español: Qué significa PARP Inhibitor

Beginner 6 min readEditorial review complete

What Does PARP Inhibitor Mean?

PARP inhibitor: what it usually means, what it does not prove, and what to ask next.

AI-assisted and source verified. Not reviewed by a healthcare professional unless specifically stated.

Sources last checked: 2026-07-20Last updated: 2026-07-20Next planned review: 2027-07-20

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Our editorial processHow we use AIReport an error

NCI source

National Cancer Institute - Definition of PARP Inhibitor

Visual summary for What Does PARP Inhibitor Mean?

The short answer

PARP inhibitor is report language that needs context. In treatment plans and biomarker-driven therapy discussions, it is a targeted therapy class that blocks PARP, an enzyme involved in DNA repair. This page explains the plain-language meaning, limits, likely next questions, and why your care team must interpret it with the rest of your results.

  • PARP inhibitor has a specific meaning in treatment plans and biomarker-driven therapy discussions.

  • The phrase alone is not the whole diagnosis or treatment plan.

  • The next step depends on the full report, prior tests, symptoms, and your cancer history.

  • Ask what the finding changes, what remains uncertain, and when you will review the plan.

Choose how you want to understand this

The full explanation.

The short answer

In plain language, PARP inhibitor is a targeted therapy class that blocks PARP, an enzyme involved in DNA repair. You may see this in treatment plans and biomarker-driven therapy discussions. The wording is meaningful, but it is only one piece of the bigger report.

What it does not prove

It is not appropriate for every cancer; BRCA, HRD, cancer type, prior treatment, and approval context matter.

Why the setting matters

The same phrase can carry different weight depending on why the test was done, what body part was examined, what older reports showed, and whether you already have a cancer diagnosis. Reports are written for clinicians, so the phrase often assumes background that is not obvious in a portal result.

What usually happens next

The next step may be follow-up, comparison with older records, repeat imaging, biopsy, treatment discussion, or no immediate action. A useful practical step is to ask what biomarker supports it, whether inherited genetic testing is needed, and what side effects are monitored.

Questions that make the visit clearer

Ask: Is this a final diagnosis or a risk category? What part of the report matters most? What finding are we acting on? What are we watching? What would make the plan change?

How to use the report before your appointment

Do not try to interpret one phrase in isolation. Save the full report, note the impression section, gather older reports if you have them, and write down the exact question you want answered. The report decoder can help translate wording while you wait for the care team.

Related report help

You can also use the report hub, the report decoder, Understanding Your Pathology Report, and Biomarker Testing.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

What does PARP inhibitor mean?

In general, PARP inhibitor is a targeted therapy class that blocks PARP, an enzyme involved in DNA repair.

Does it mean cancer?

It is not appropriate for every cancer; BRCA, HRD, cancer type, prior treatment, and approval context matter.

What should I ask next?

A practical next question is to ask what biomarker supports it, whether inherited genetic testing is needed, and what side effects are monitored.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Look up related pathology, imaging, biomarker, and treatment-response language.

Decode another report term
Quick quiz

Test your knowledge

0 of 3 answered

  1. Q1.What is the safest way to interpret PARP inhibitor?
  2. Q2.What is a useful next question?
  3. Q3.Why might older records matter?

This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status: Editorial review complete This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Related learning map

How this explanation connects to 11 other things you can explore — related topics, terms, questions, practice, and its NCI source.

What Does PARP Inhibitor Mean?